Gilead Sciences (GILD) Selling, General & Administrative (2009 - 2026)
Gilead Sciences' Selling, General & Administrative was $1.92 billion in Q2 2026, up 40.7% from $1.37 billion a year earlier and up 32.4% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Selling, General & Administrative (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Gilead Sciences' Selling, General & Administrative was $6.52 billion through Jun 30, 2026, up 9.4% year-over-year; for FY2025, it came in at $5.77 billion, down 5.2% from FY2024.
- Selling, General & Administrative shows a five-year compound annual growth rate of 2.3% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $6.09 billion in FY2024 (unchanged), $6.09 billion in FY2023 (+7.4%), $5.67 billion in FY2022 (+8.1%) and $5.25 billion in FY2021 (+1.8%).
- The Q2 2026 figure marks the highest quarterly Selling, General & Administrative since Q4 2022.
- Compared with a year earlier, Selling, General & Administrative was higher in four of the last eight quarters, with growth averaging 7.9%.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q2 2026 (growth of 40.7%); the worst was Q2 2024 (a decline of 25.5%).
- Per Business Quant data, GILD's Selling, General & Administrative in the three quarters before Q2 2026 was $1.45 billion (Q1 2026), $1.79 billion (Q4 2025) and $1.36 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 582.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.92 Bn |
| Mar 31, 2026 | 1.45 Bn |
| Dec 31, 2025 | 1.79 Bn |
| Sep 30, 2025 | 1.36 Bn |
| Jun 30, 2025 | 1.37 Bn |
| Mar 31, 2025 | 1.26 Bn |
| Dec 31, 2024 | 1.91 Bn |
| Sep 30, 2024 | 1.43 Bn |
| Jun 30, 2024 | 1.38 Bn |
| Mar 31, 2024 | 1.38 Bn |
| Dec 31, 2023 | 1.61 Bn |
| Sep 30, 2023 | 1.32 Bn |
| Jun 30, 2023 | 1.85 Bn |
| Mar 31, 2023 | 1.32 Bn |
| Dec 31, 2022 | 2.02 Bn |
| Sep 30, 2022 | 1.21 Bn |
| Jun 30, 2022 | 1.36 Bn |
| Mar 31, 2022 | 1.08 Bn |
| Dec 31, 2021 | 1.65 Bn |
| Sep 30, 2021 | 1.19 Bn |
API Access
Gilead Sciences Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();